Covered recipient · General Payments record
MELISSA ERIN GRIFFIN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,599.95
- Reported across 104 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $245.03 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | $123.79 | 1 |
| Abbott Laboratories | $30.89 | 2 |
| Otsuka America Pharmaceutical, Inc. | $20.63 | 1 |
| GlaxoSmithKline, LLC. | $19.78 | 1 |
| Acerta Pharma LLC | $19.77 | 1 |
| TOLMAR, INC. | $15.11 | 1 |
| Novo Nordisk AS | $15.06 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $14.16 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124844032 | CMS |
| Abbott Laboratories | $16.73 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124844034 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.77 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105869341 | CMS |
| GlaxoSmithKline, LLC. | $19.78 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116061442 | CMS |
| Novo Nordisk Inc | $15.06 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096594636 | CMS |
| Otsuka America Pharmaceutical, Inc. | $20.63 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118901376 | CMS |
| Paratek Pharmaceuticals, Inc. | $123.79 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113902025 | CMS |
| Tolmar, Inc. | $15.11 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138716388 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.